Abstract
The effects of systemically injected caerulein, a cholecystokinin octapeptide analogue, on GABA content and turnover have been studied in various regions of rat brain. Caerulein decreased GABA levels in the nucleus accumbens, tuberculum olfactorium and substantia nigra and diminished GABA turnover rates in the striatum, nucleus accumbens and substantia nigra, as estimated from the rate of GABA accumulation after inhibition of GABA transaminase by aminooxyacetic acid (AOAA). These results indicate the effect of caerulein on the utilization of GABA in specific cerebral regions and suggest that the GABAergic system is involved in the mechanism of action of peripherally administered caerulein.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cheramy A, Nieoullon A, Glowinsky J (1978) GABAergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat. Eur J Pharmacol 48:281–295
Deschodt-Lankman M, Bui ND, Noyer M, Christophe J (1981) Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography. Regul Pept 2:15–30
Grace AA, Bunney BS (1979) Paradoxical excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur J Pharmacol 59:211–218
Grace AA, Bunney BS (1985) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 333:271–284
Groves PM, Wilson CJ, Young SJ, Rebec GV (1975) Self-inhibition by dopaminergic neurons. Science 190:522–529
Hamamura T, Kazahaya Y, Otsuki S (1989) Ceruletide suppresses endogeneous dopamine release via vagal system, studied by in vivo intracerebral dialysis. Brain Res 483:78–83
Hommer DW, Palkovits M, Crawley JN, Paul SM, Skirboll LR (1985) Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components. J Neurosci 5:1387–1392
Iadarola MJ, Raines A, Gale K (1979) Differential effects ofn-dipropylacetate and amino-oxyacetic acid on γ-aminobutyric acid levels in discrete areas of rat brain. J Neurochem 33:1119–1123
Iadarola MJ, Gale K (1981) Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol Cell Biochem 39:305–330
König JFR, Klippel RA (1967) The rat brain; a stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams & Wilkins, Bartimore
Kuroki T, Matsumoto T, Hirano M, Kagoshima H, Yao H, Uchimura H, Nakamura K, Nakahara T (1987) Long-lasting effect of systemically administered caerulein on monoaminergic neuronal pathways in rat brain. Neuropeptides 9:169–176
Löscher W (1981) Correlation between alterations in brain GABA metabolism and seizure excitability following administration of GABA aminotransferase inhibitors and valproic acid — a reevaluation. Neurochem Int 3:397–404
Lowry O, Rosebrough N, Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Lucignani G, Porrino LJ, Tamminga C (1984) Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism. Eur J Pharmacol 101:147–151
Marco E, Mao CC, Cheney DL, Revuelta A, Costa E (1976) The effects of antipsychotics on the turnover rate of GABA and acetylcholine in rat brain nuclei. Nature 264:363–365
Matsumoto T, Nakahara T, Uchimura H, Hirano M, Yokoo H, Nakamura K, Oomagari K (1984) Effect of systemically administered caerulein on dopamine metabolism in rat brain. Brain Res 324:195–199
McGeer PL, McGeer EG (1975) Evidence for glutamic acid decarboxylase-containing interneurons in the neostriatum. Brain Res 91:331–335
Moroji T, Hagino Y (1987) Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice. Neuropeptides 9:217–224
Nakamura K, Matsumoto T, Hirano M, Kagoshima H, Kuroki T, Yao H, Uchimura H, Nakahara T (1987) Mass fragmentographic determination of γ-aminobutyric acid and glutamic acid in discrete amygdaloid nuclei of rat brain. J Neurochem 48:1842–1844
Nishikawa T, Tanaka M, Koga I, Uchida Y (1985) Biphasic and long-lasting effect of ceruletide on tardive dyskinesia. Psychopharmacology 86:43–44
Pericic D, Walters JR, Chase TN (1977) Effect of diazepam and pentobarbital on aminooxyacetic acid-induced accumulation of GABA. J Neurochem 29:839–846
Scheel-Krüger J, Arnt J, Magelund G, Olianas M, Przewlocka B, Christensen AV (1980) Behavioural functions of GABA in basal ganglia and limbic system. Brain Res Bull 5:261–267
Shimoyama M, Kito S (1989) Effect of cerulein on in vivo release of acetylcholine from the rat striatum. Brain Res 492:381–384
Skirboll LR, Grace AA, Hommer DW, Rehfeld J, Goldstein M, Hökfelt T, Bunney BS (1981) Peptide-monoamine coexistence: studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 6:2111–2124
Vanderhaegen JJ, Lotstra F, de Mey J, Gilles C (1980) Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc Natl Acad Sci USA 77:1190–1194
Van Ree JM, Gaffori O, De Wied D (1983) In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. Eur J Pharmacol 93:63–78
Waszczak BL, Eng N, Walters JR (1980) Effects of muscimol and picrotoxin on single unit activity of substantia nigra neurons. Brain Res 188:185–197
Zetler G (1981) Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol. Neuropharmacology 20:277–283
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakamura, K., Matsumoto, T., Hirano, M. et al. Changes in GABA content and turnover in discrete regions of rat brain after systemic administration of caerulein. Psychopharmacology 101, 73–76 (1990). https://doi.org/10.1007/BF02253721
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02253721